Login
 
Forgotten password
Sitemap Contact

Management

CEO
Vincent Charlon

Contact Info

Anergis
Chemin du Polny 34b
1016  Lausanne
Switzerland
www.anergis.ch

Google Map

Get in touch!

 Security code

Anergis

«Treatment and diagnosis of allergy»

Presented by CTI Invest on 08.09.2010

PodcastTeaserLinkVideo Podcast Preview (log in to watch full podcast)

Anergis is a biiopharmaceutical company developing unique ultra-fast and safe specific immmunotherapy products against allergies. Anergis lead-product against tree pollen allergies has succcessfully completed a Phase I/IIA clinical study in allergic patients.

Coach: No coach nomited for the moment.
Founded 2001
Industry Biotech & Life Sciences
Status looking for investor


Awards

Newsletter

Stay up to date: Register

Contact CTI Invest

Jean-Pierre Vuilleumier
Managing Director
P: +41 79 251 32 09